Tremfya 200 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FQV5B
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $30,584
Award facts
- Contract value 100% obligated
- $30,583.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $30,583.72 to AmerSourceBergen Drug Corp for TREMFYA 200 mg/2 ml pen auto-injectors on January 28, 2026, with an ultimate completion date of February 19, 2026. This firm fixed-price, non-set-aside contract is performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerSourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 and extending through December 31, 2031, which serves as the primary vehicle for supplying pharmaceutical products and medical supplies to military healthcare programs globally.
TREMFYA is a prescription biologic medication indicated for the treatment of psoriasis and psoriatic arthritis. As a critical pharmaceutical distributor, AmerSourceBergen leverages its comprehensive DLA IDC to deliver specialty medications, brand-name and generic drugs, vaccines, and associated medical supplies across multiple therapeutic domains to support military treatment facilities and veterans' healthcare programs. The company's selection through open competition demonstrates its capability to meet federal procurement requirements for essential pharmaceutical commodities required by the Department of Defense health system.
Quick answers
Who was awarded contract SPE2DR26FQV5B?
SPE2DR26FQV5B was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26FQV5B worth?
The government has obligated $30,584 on SPE2DR26FQV5B.
Is contract SPE2DR26FQV5B an order under another contract?
Yes. SPE2DR26FQV5B is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQV5B competed?
The extent of competition for SPE2DR26FQV5B was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award